Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 16
|
ECE2008
|
Next issue
10th European Congress of Endocrinology
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Sex steroids in the regulation of bone metabolism in men
ea0016eje1
European Journal of Endocrinology Prize Lecture
ea0016eje1biog
The Geoffrey Harris Prize Lecture
From Goeffrey Harris's hypothalamic principle to a unified theory of stress and stress system disorders
ea0016gh1
Geoffrey Harris Prize Lecture
ea0016gh1biog
Plenary Lectures
Estrogens and cardiovascular disease
Estrogens and cardiovascular disease
ea0016pl1
Let’s get older-lessons to learn from centenarians
Why did Moses live to be 120?
ea0016pl2
The red wine hypothesis: resveratrol and human metabolism
A cofactor network that controls PGC-1[alpha] activity and energy homeostasis
ea0016pl3
Berthold lecture of the German Endocrine Society
Abstract unavailable
ea0016pl4
Too little and too much insulin – lessons to learn from newborns
Too little and too much insulin: lessons from newborns
ea0016pl5
Graves’ ophthalmopathy – problems solved and new questions to be answered
Graves' ophthalmopathy: problems solved and new questions to be answered
ea0016pl6
When and why do we wake up – the endocrine regulation of sleep in humans
Decreased sleep duration and quality: novel risk factors for obesity and diabetes
ea0016pl7
Central regulation of appetite and body weight – the role of peripheral signals
Central regulation of appetite and body weight: the role of peripheral signals
ea0016pl8
Symposia
The trick is the combination
Treatment of hyperthyroidism: block and replace versus titration
ea0016s1.1
The combination of GH/IGF-I makes the difference!
ea0016s1.2
Medical treatment of acromegaly: dual blockade with a somatostatin analog and Pegvisomant
ea0016s1.3
The trick is the combination
ea0016s1.4
TGFβ superfamily
BMP to the bone
ea0016s2.1
Integration of skeletal regulatory signals in nuclear microenvironments
ea0016s2.2
TGF-[beta] family ligands in glucose and fat homeostasis in adults
ea0016s2.3
The dependence receptor notion: when apoptosis regulates tumor progression and metastasis
ea0016s2.4
Gene/environment interactions in autoimmune endocrine disease
Why is the incidence of autoimmune diseases increasing in the modern world?
ea0016s3.1
Genome-wide association studies and hormone-dependent cancers
ea0016s3.2
Gene environment interactions in type 1 diabetes
ea0016s3.3
Gene-environment interactions in thyroid autoimmunity
ea0016s3.4
Is there a crisis for male reproduction?
Deterioration of male reproductive function in Europe: geographical differences
ea0016s4.1
Life style factors and chemical exposures impair male reproductive development and function in humans
ea0016s4.2
Metabolic syndrome in Klinefelter syndrome (47,XXY)
ea0016s4.3
Metabolic aspects of testosterone replacement
ea0016s4.4
Protein modifications - proteomics
Comparative proteomics as a tool in biology: the protein microscope
ea0016s5.1
Applying proteomics to thyroid tumour diagnosis
ea0016s5.2
Targeting ubiquitin networks
ea0016s5.3
Progesterone receptor responses modified by SUMO in the endometrium
ea0016s5.4
Insights in pancreatic development and new clinical aspects
Embryonic pancreatic development
ea0016s6.1
The zinc-finger factor Insm1 (IA-1) is essential for the development of endocrine cells of the pancreas, intestine and adrenal gland
ea0016s6.2
Hyperinsulinism in humans
ea0016s6.3
Carboxylester lipase (CEL) VNTR links exocrine dysfunction to endocrine dysfunction
ea0016s6.4
The functions of peripheral ghrelin
Ghrelin and the gonads
ea0016s7.1
Ghrelin and the endocrine pancreas
ea0016s7.2
Ghrelin and bone
ea0016s7.3
Peptidyl growth hormone secretagogues in cardioprotection
ea0016s7.4
Nuclear receptors
LXR
ea0016s8.1
Kinase signaling and retinoic acid nuclear receptors
ea0016s8.2
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
ea0016s8.3
Estrogen-related receptors as regulators of energy homeostasis and adaptive metabolism
ea0016s8.4
New aspects of adrenal disease
The role of toll-like receptors
ea0016s9.1
The expanding spectrum of DAX1 and SF1 mutations
ea0016s9.2
Replacement and QoL In patients with adrenal insufficiency
ea0016s9.3
Genetics of chromaffin tumours
ea0016s9.4
Pro & Con – is there a rationale for ISS treatment with GH
Abstract unavailable
ea0016s10
Epigenetics in endocrinology
Epimutations in the human genome
ea0016s11.1
Mechanisms of selective gene expression in development
ea0016s11.2
Epigenetics in mammalian development
ea0016s11.3
Imprinting in human disease: lessons from the study of transient neonatal diabetes
ea0016s11.4
Addicted to food?
The Selfish brain: competition for energy resources
ea0016s12.1
Peptide YY: cure for obesity?
ea0016s12.2
Hypothalamic regulation of energy balance
ea0016s12.3
Metabolic and reward cues affect the central clock in the brain
ea0016s12.4
Pro & Con – HRT or more: Androgen therapy for the aging male
Abstract unavailable
ea0016s13
Basic highlights
Direct visualization of cyclic AMP levels in three dimensional cultures of thyroid follicles
ea0016s14.1
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
ea0016s14.2
Variants of the phosphodiesterase 11A (PDE11A4) gene and genetic predisposition to adrenocortical tumors (ACT)
ea0016s14.3
Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa
ea0016s14.4
KLF11 differentially regulates PDX1-induced activation of the human insulin promoter in rodent beta-cells and human non-beta-cells
ea0016s14.5
Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance
ea0016s14.6
GH treatment of syndromic short stature - facts and myths
SHOX deficiency: does GH treatment do any good?
ea0016s15.1
GH therapy in Noonan syndrome - facts and myths
ea0016s15.2
GH therapy in children with Prader Willi Syndrome (PWS)
ea0016s15.3
Consensus on GH Treatment in SGA
ea0016s15.4
New insights in PCOS
Definition of PCOS
ea0016s16.1
New insights in polycystic ovary syndrome
ea0016s16.2
Vascular markers in PCOS
ea0016s16.3
Treatment of PCOS
ea0016s16.4
Thyroid cell biology
Basic mechanisms of thyroid development
ea0016s17.1
Growth factors involved in thyroid cells differentiation
ea0016s17.2
Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene: Loss of the CBX7 gene.ll
ea0016s17.3
Novel insights on the Na+/I- symporter (NIS): it mediates electroneutral active transport of the environmental pollutant perchlorate
ea0016s17.4
Doping – an issue for clinical endocrinologists
Indirect evidence suggesting hormone abuse: can it be proof of doping in sports?
ea0016s18.1
Doping with androgens
ea0016s18.2
Distinction between endogenous and exogenous GH
ea0016s18.3
Distinction between endogenous and exogenous erythropoietin (EPO)
ea0016s18.4
Hormone receptors and adipose tissue
The family of corticotropin-releasing hormone (CRH) peptides: important regulators of adipocyte function
ea0016s19.1
Corticosteroid receptors and adipocytes
ea0016s19.2
Multi-layered receptor interactions in ghrelin-induced fat deposition
ea0016s19.3
Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome, and obesity
ea0016s19.4
Translational highlights
sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro
ea0016s20.1
SF-1 knockout mice as a model for hormone independent brain sexual differentiation
ea0016s20.2
Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter
ea0016s20.3
Recent advances in stereological methods for studying microvessels in endocrine organs
ea0016s20.4
V206M polymorphism of the SLC26A6 gene encoding a Cl--oxalate transporter in patients with primary hyperparathyroidism and kidney stones
ea0016s20.5
A functional AMH polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients
ea0016s20.6
Pro & Con – Is there a benefit for treatment of subclinical hypo?
Abstract unavailable
ea0016s21
The good side of exercise
Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
ea0016s22.1
The good side of exercise: inflammation and physical activity
ea0016s22.2
Why does physical exercise improve insulin sensitivity, the role of adipose tissue?
ea0016s22.3
Exercise and bone
ea0016s22.4
Towards a better understanding of hypothalamic–pituitary disorders
Pituitary development and congenital hypopituitarism (CH)
ea0016s23.1
Atypical G-protein coupled receptor expression in pituitary tumors
ea0016s23.2
Growth factors in pituitary tumour development
ea0016s23.3
Cell cycle control and proliferative diseases of the pituitary
ea0016s23.4
State of the art in the therapy of pituitary disease
Nonfunctioning pituitary macroadenomas: treatment and follow-up
ea0016s24.1
Medical therapy of Cushing's disease
ea0016s24.2
The sequealae of Cushing's disease
ea0016s24.3
Development of a disease-related QoL-questionnaire for Cushing's disease
ea0016s24.4
Stem cell and regeneration
Generation and patterning of patient-specific pluripotent stem cells
ea0016s25.1
Stem cells in the gonads: novel options for fertility preservation?
ea0016s25.2
The cell biology of neural stem and progenitor cells
ea0016s25.3
Beta cell progenitor niche(s) and derivation of such cells from human ES cells
ea0016s25.4
New therapeutic options in diabetes
Islet transplantation
ea0016s26.1
Plasticity of human pancreatic beta cells
ea0016s26.2
Emerging therapeutic approaches to preserve beta cell function in type 1 DM
ea0016s26.3
The one and only? Gene driving Type2 DM
ea0016s26.4
Nodules and more: new aspects of thyroid disorders
Management of thyroid nodules: the European and the USA way
ea0016s27.1
Management of differentiated thyroid cancer
ea0016s27.2
Therapeutic options and dilemmas in medullary thyroid carcinoma
ea0016s27.3
Nodules and more
ea0016s27.4
GH: structure–function relationship
Plasticity in the growth hormone axis
ea0016s28.1
The contribution of autocrine human growth hormone to neoplasia
ea0016s28.2
Multireceptor ligands in the treatment of pituitary adenomas
ea0016s28.3
Trafficking and function of GHR and the role of GHBP
ea0016s28.4
Too early-too late: the timing of puberty
The systems biology of puberty-searching for hypothalamic gene networks
ea0016s29.1
Long acting GnRH analogues in the treatment of central precocious puberty
ea0016s29.2
Estrogen and kisspeptin regulation of GnRH neurons at puberty
ea0016s29.3
Human genetics of pubertal onset
ea0016s29.4
Clinical highlights
Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene
ea0016s30.1
Contrast-enhanced ultrasound of adrenal mass: differentiation between benign and malignant lesions
ea0016s30.2
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma
ea0016s30.3
Evaluation of endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism
ea0016s30.4
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline: dose and treatment duration effect
ea0016s30.5
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial
ea0016s30.6
Meet the Expert Sessions
(1)
The impact of abdominal obesity
ea0016me1
Rational for using insulin analogues in the treatment of diabetes mellitus
ea0016me2
Contraception in the new millennium
ea0016me3
Two-photon microscopy of cancer invasion and metastasis
ea0016me4
How valid is a biochemical diagnosis of chromaffin tumors?
ea0016me5
Beyond the bone: sporadic and hereditary hyperparathyroidism
ea0016me6
The sequelae of brain injury: is the pituitary involved?
ea0016me7
microRNA
ea0016me8
Prolactin: an underestimated hormone
ea0016me9
How to prevent osteoporosis?
ea0016me10
More than a change of nomenclature: disorders of sex development (DSD)
ea0016me11
Metabolomics and metabonomics
ea0016me12
Endocrine management of gonadal tissue conservation
ea0016me13
Management of GI-NET
ea0016me14
Histopathology of thyroid tumors
ea0016me15
HRT in women: a never ending story?
ea0016me16
Oral Communications
Neuroendocrinology and pituitary
Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage in 921 patients: the German Interdisciplinary Database
ea0016oc1.1
The adequacy of thyroxine replacement in hypopituitary patients
ea0016oc1.2
Limited effects of growth hormone replacement in adults with growth hormone deficiency after treatment for acromegaly
ea0016oc1.3
Pasireotide (SOM230) effectively reduces pituitary tumor volume in patients with active acromegaly: preliminary 6-month results from a phase II extension study
ea0016oc1.4
Cardiac performance after long-term treatment with Pegvisomant in patients with acromegaly: a radionuclide angiography study
ea0016oc1.5
The metabolic effects of ghrelin and glucocorticoids are mediated by AMP-activated protein kinase (AMPK) and endogenous cannabinoids
ea0016oc1.6
Intermittent high glucose concentrations reduce neuronal precursor proliferation by altering the IGF system: the involvement of the neuroprotective factor seladin-1
ea0016oc1.7
Differential sensitivity of men and women to anorexigenic and memory improving effects of intranasal insulin
ea0016oc1.8
Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men
ea0016oc1.9
Thyroid
Analysis of early gene expression in mouse thyroid development
ea0016oc2.1
Identification of 25 novel NKX2-1 gene mutations in 100 patients with broad spectrum of brain and thyroid dysfunctions
ea0016oc2.2
Global proteomic analysis in human thyroid proliferative/neoplastic primary culture lines
ea0016oc2.3
Identification and enrichment of thyroid stem cells in anaplastic cell lines
ea0016oc2.4
Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair
ea0016oc2.5
Ga-68-Dotatoc PET detects somatostatin receptors in normal thyroids and various thyroid pathologies
ea0016oc2.6
Impact of resistance to thyroid hormone on the cardiovascular system in adult humans
ea0016oc2.7
Graves' ophthalmopathy in patients treated with radioiodine I-131
ea0016oc2.8
Subclinical hypothyroidism in older patients: an analysis of natural course and risk factors for the thyroid failure
ea0016oc2.9
Diabetes and obesity
Interaction of hypothalamic G-protein-coupled receptors (GPCRs) involved in weight regulation
ea0016oc3.1
Adiponectin inhibits AMP kinase activity and increases insulin secretion in MIN6 cells
ea0016oc3.2
Regulation of lipolysis by corticotropin releasing hormone in brown adipocytes
ea0016oc3.3
Fatty acid-induced induction of TLR-4/NF[kappa]B-pathway in adipocytes links nutritional signaling with innate immunity
ea0016oc3.4
Hormonal regulation of 11-[beta]-HSD1 expression and activity in differentiated 3T3- L1 adipocytes
ea0016oc3.5
Transcriptional control of hepatic and systemic lipid metabolism by the nuclear receptor co-factor RIP140
ea0016oc3.6
Impact of metformin on gene expression, glucose uptake and lipolysis in adipocytes
ea0016oc3.7
Plasma endothelin as a biochemical marker of endothelial dysfunction in endocrine diseases with increased cardiovascular risk
ea0016oc3.8
Effect of baseline sample characteristics, comparator drug, co-interventions and rosiglitazone doses on the risk of myocardial infarction: multivariable lineal regression analysis
ea0016oc3.9
Bone and adrenal
Inactivation of the Carney complex (CNC) gene 1 (PKA regulatory subunit 1A, PRKAR1A) by interference RNA alters multiple signaling pathways and decreases apoptosis
ea0016oc4.1
Reduced fertility rates and high prevalence of testicular adrenal rest tumors (TART) in male patients with congenital adrenal hyperplasia
ea0016oc4.2
BMP dependent modulation of adrenocortical growth and function
ea0016oc4.3
Comparison of different test systems for the screening of inhibitors of CYP11B enzymes
ea0016oc4.4
Comparison of 1-mg versus 8-mg dexamethasone suppression tests (DST) in patients with clinically inapparent adrenal adenoma
ea0016oc4.5
Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids
ea0016oc4.6
Molecular analysis of the calcium sensing receptor (CaSR) gene in 40 patients suspected to have familial hypocalciuric hypercalcemia (FHH)
ea0016oc4.7
Incidental parathyroidectomy during thyroid surgery: outcome, follow-up and management of 231 patients treated between 1989 and 2007
ea0016oc4.8
Teriparatide (TPTD) treatment followed by either zoledronic acid (ZOL) 5 mg once yearly or strontium ranelate (SR) 2 g daily: preliminary results from the ZOSTER-Study
ea0016oc4.9
Reproduction
Female fertility defects and puberty delay in micelacking activin receptor-like kinase 7
ea0016oc5.1
The T222P mutation of the LGR8 gene is not causative for cryptorchidism
ea0016oc5.2
Prokineticin-2 and prokineticin receptor-2 gene analysis in men with Kallmann syndrome or normosmic hypogonadotropic hypogonadism
ea0016oc5.3
Molecular and functional characterization of BMP15 variants associated with secondary amenorrhea and premature ovarian failure (POF)
ea0016oc5.4
Prevalence of low testosterone levels in primary care in Germany: cross-sectional results from the DETECT study
ea0016oc5.5
Effects of pregnancy on GH/IGF-1 concentrations in acromegalic women
ea0016oc5.6
Hepatic steatosis is not a feature of young lean women with polycystic ovarian syndrome
ea0016oc5.7
The effect of estrogens plus cyproterone acetate or orchiectomy on serum insulin like factor 3 (INSL3) levels in transsexual men
ea0016oc5.8
Cognitive disabilities in the novel object task of male mice carrying a supernumerary X chromosome (41, XX*Y)
ea0016oc5.9
Metabolism and cardiovascular
The signaling profile of recombinant human orexin-2 receptor (OX2R)
ea0016oc6.1
Human adipocytes secrete new cardiodepressant factors: a direct link between obesity and heart failure
ea0016oc6.2
Visfatin induces MMP-2/9 activation in human vascular endothelial cells via nuclear factor-[kappa]B
ea0016oc6.3
Lipolysis in subcutaneous tissue after intranasal administration of ACTH(4-10) is associated with an increased baroreceptor reflex sensitivity
ea0016oc6.4
Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women
ea0016oc6.5
Androgens increase blood pressure in orchiectomized male Wistar rats similar to high salt diet
ea0016oc6.6
The mineralocorticoid receptor induces pro-inflammatory effects in white adipocytes and is essential for adipogenesis
ea0016oc6.7
Chronic prostaglandin excess results in adipose tissue wasting through increased substrate utilization
ea0016oc6.8
The histone deacetylase inhibitor valproic acid (VPA) confers an estrogen-sensitive 'phenotype' to estrogen receptor-negative breast cancer cells MDA-MB 231
ea0016oc6.9
Poster Presentations
Adrenal
Finasteride cream and idiopathic hirsutism
ea0016p1
Male sexual hormone effects on the adrenal cortex activity in a Saharan desert rodent, Psammomys obesus (Cretzschmar, 1828)
ea0016p2
Frequency of adrenal tumor in Japanese patients with type 2 diabetes mellitus
ea0016p3
Might the response of cortisol to oral glucose tolerance test be used for the differential diagnosis of Cushing's syndrome and pseudo-Cushing's states?
ea0016p4
Modulation of proteomic profile in h295r adrenocortical cell line induced by mitotane
ea0016p5
Pheochromocytoma of the second adrenal gland 17 years after first adrenalectomy in PPS: case report
ea0016p6
Health related quality of life differs between three replacement therapies in adrenal insufficiency
ea0016p7
Differences in quality of life between twice and thrice daily application of hydrocortisone in adrenal insufficiency
ea0016p8
How does aldosterone renin ratio impact blood pressure levels? A Cross-Sectional Study of 3252 Normo- and hypertensive patients referred to coronary angiography
ea0016p9
Effect of storage temperatures and different coagulants on stability of plasma ACTH
ea0016p10
Phosphodiesterase inhibitors and adrenal response to exercise-related stress
ea0016p11
RNA interference inhibits VEGF and EG-VEGF expression of H295R human adrenocortical carcinoma cell line
ea0016p12
The prevalence of non-classic adrenal hyperplasia among Tturkish women with hirsutism
ea0016p13
Coincidence of pheochromocytoma and adrenocortical carcinoma at the same adrenal gland at patient with neurofibromatosis
ea0016p14
The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas: hormonal and mutation screening
ea0016p15
The role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI)
ea0016p16
Adrenal tumours in patients with a history of malignancy
ea0016p17
Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency
ea0016p18
Angiogenic status of human adrenocortical tumors
ea0016p19
Diagnostic potential of GC--MS urinary steroid profiling in the diagnosis of CAH due to 21-OH deficiency in neonates and infants
ea0016p20
11[beta]-hydroxysteroid dehydrogenase 2 activity is elevated in extreme obese subjects and negatively associated with insulin sensitivity
ea0016p21
Free fatty acids affect urinary excretion of androgen precursors thereby linking metabolism and hyperandrogenemia in vivo: results of a randomized, controlled trial
ea0016p22
Effects of free fatty acids on adrenocorticotropin secretion and metabolic glucocorticoid pattern in healthy young women
ea0016p23
Association of diabetes mellitus and arterial hypertension in adrenal incidentaloma
ea0016p24
Dehydroepiandrosterone (DHEA) exerts a prominent effect on chromaffin PC12 cell differentiation processes
ea0016p25
Glucocorticoid receptor gene polymorphisms and bone mineral density in hpa axis disorders
ea0016p26
Modulation of adrenocortical aldosterone and cortisol synthesis by in vitro oxidized low density lipoprotein
ea0016p27
Establishment of a mutagenesis screen to identify mice with high aldosterone levels
ea0016p28
Late night salivary cortisol in the diagnosis of Cushing's syndrome
ea0016p29
Hormonal, metabolic and bone evaluation in a series of adrenal incidentalomas
ea0016p30
Follow-up in a group of 166 adrenal incidentaloma patients
ea0016p31
Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing's disease
ea0016p32
Salt wasting form of classic congenital adrenal hyperplasia (cah) due to 21-hydroxylase deficiency: an overview in adult life
ea0016p33
Renal excretion rates of free cortisol, free cortisone and dehydroepiandrosterone metabolites, but not renal indices of cortisol secretion are associated with urinary volume in healthy children
ea0016p34
Glucocorticoids and body fat are associated with urinary excretion rates of uric acid and oxalate, but not of calcium in healthy children
ea0016p35
Aberrant cortisol responses in adrenal incidentalomas: a study on evaluation and management of 20 patients
ea0016p36
The German Conn's registry: comorbidities in over 700 patients with primary hyperaldosteronism
ea0016p37
Retrospective clinical data on more than 160 pheochromocytoma in three east german endocrine centers
ea0016p38
Impaired endothelial morphology and function in patients with subclinical Cushing's syndrome due to single adrenocortical adenomas
ea0016p39
Comparison of strategies for biochemical diagnosis of primary aldosteronism in German academic centres
ea0016p40
Addison's disease: aetiological role of oncological factors
ea0016p41
Diurnal salivary cortisol in young adult-onset diabetes mellitus Type 1 patients
ea0016p42
Insulin sensitivity calucated by HOMA, QUIQI and G/IR in patients with adrenal incidentaloma
ea0016p43
Quantitative real time RT-PCR of CYP11B2 (aldosterone synthase) to confirm the diagnosis of aldosterone-producing adenomas
ea0016p44
Renal function in patients with primary aldosteronism: comparison with essential hypertension
ea0016p45
Adrenal retinoid receptors: new findings and new questions
ea0016p46
Screening for aberrant peptide hormone responsiveness in primary aldosteronism
ea0016p47
Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome
ea0016p48
Evaluation of aldosterone to renin concentration ratio as a reliable screening parameter for primary aldosteronism applying currently available assays
ea0016p49
Metabolic and cardiovascular profile in adult patients with addison's disease under conventional glucocorticoid replacement therapy
ea0016p50
Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice
ea0016p51
Relation between serum adiponectin level, subclinical Cushing's syndrome and non-functional adrenal incidentaloma
ea0016p52
Subclinical autonomous cortisol hypersecretion by adrenal incidentalomas may be intermittent: results from a long term follow-up study
ea0016p53
Preoperative paroxysmal attacks are not predictive of intraoperative hemodynamic changes in patients undergoing laparoscopic adrenalectomy for pheochromocytoma
ea0016p54
Adrenal crisis in primary and secondary adrenal insufficiency: frequency and causes
ea0016p55
The role of toll-like receptors in adrenal gland inflammatory response and tumorigenesis
ea0016p56
The sodium to urinary sodium to potassium to urinary potassium (SUSPUP) ratio in primary aldosteronism
ea0016p57
Characterization and differentiation of chromospheres isolated from bovine adrenal medulla
ea0016p58
Evidence for the involvement of endothelial cell products in adrenal CITED2 expression
ea0016p59
Intraadrenal production of ACTH in macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: its role in the physiopathology of hypercortisolism
ea0016p60
A case of renin-producing adrenocortical carcinoma with Cushing's syndrome: in vitro effect of serotonin on renin and cortisol secretions
ea0016p61
Bone and calcium
Recognition of osteoporosis and analysis of influencing factors
ea0016p62
Comparison of ultrasonography and 99mtechnetium sestamibi in localization of parathyroid adenoma in primary hyperparathyroidism
ea0016p63
Daidzein unlike other isolated isoflavones, preserves bone architecture in ovariectomized female rats in vivo
ea0016p64
Surgical management of renal hyperparathyroidism: a preliminary series report
ea0016p65
Osteopenia/osteoporosis in adult thalassemic patients: contribution of growth hormone - insulin-like growth factor I deficiency
ea0016p66
Digital X-ray radiogrammetry in followed change of bone mineral density after the treatment in postmenopausal women
ea0016p67
BsmI, ApaI, TaqI, FokI polymorphisms of vitamin D receptor (VDR) gene and bone mineral density in women with Graves' disease
ea0016p68
Bone metabolism in hypothalamic obesity
ea0016p69
Birth weight and the relation to lean body mass and BMC in healthy men at peak bone mass: results from the Odense Androgen Study
ea0016p70
Every nanogram of 25(OH)D makes a difference: subgroup analysis of institutionalized patients with vitamin D deficiency in Austria
ea0016p71
Parathyroid hormone and glucocorticoid cooperatively induce RANKL mRNA expression in osteoblasts through different mechanisms
ea0016p72
Hyperparathyroidism-jaw tumor syndrome (HPT-JT): a new mutation in the HRPT2-gene
ea0016p73
Dramatic hypocalcaemia as a cause of generalized seizures following thyroidectomy
ea0016p74
Subclinical hypothyroidism and bone mineral density
ea0016p75
Seasonality, sun exposure, skin type and vitamin D levels influence Parathyroid Hormone related Peptide (PTHrP) metabolism during pregnancy and after delivery in mothers and their newborns
ea0016p76
The relationship between bone turnover and body weight and leptin in patients with Anorexia nervosa
ea0016p77
Usual values and usefulness of crosslaps in pediatric practice
ea0016p78
Contribution of vitamin D supplementation to the vitamin D status of infants in the age of fortified milk
ea0016p79
The influence of ESR1 gene genotype on bone mineral density in premenopausal women with Grave's disease
ea0016p80
Predictors of bone mineral density in men with primary hyperparathyroidism
ea0016p81
Primary hyperparathyroidism during pregnancy: a case report
ea0016p82
Lack of relationship between the BsmI polymorphism in the vitamin D receptor gene and the risk of glucocorticoid-induced osteoporosis in premenopausal asthmatic women on a long-term glucocorticoid therapy
ea0016p83
Intra-operative and routine intact parathyroid hormone assay on the Beckman Coulter UnicelR DxI 800
ea0016p84
Clinical and hormonal variables to predict bone mineral density loss in anorexia nervosa patients
ea0016p85
Vitamin D deficiency and supplementation in pregnancy, a randomised study of 180 women in four ethnic groups
ea0016p86
Clinical experience with Cinacalcet for treatment of persistent primary hyperparathyroidism
ea0016p87
R-568 improves transmembrane signal transduction of inactivating mutations of the calcium-sensing receptor
ea0016p88
Relationship between parity and osteoporotic fractures in postmenopausal osteoporotic women (PMOW)
ea0016p89
Relationship between osteoporosis and living/working environment
ea0016p90
Determinants of spinal deformities in adult patients with untreated growth hormone deficiency (GHD)
ea0016p91
Osteoprotegerin and bone mineral density in adult patients with celiac disease
ea0016p92
Insulin sensitivity and lipid status before and after radical treatment of primary hyperparathyroidism
ea0016p93
Scintigraphic, biochemical and clinical response to zoledronic acid treatment in patients with Paget's disease of bone
ea0016p94
Significance of bone mineral density measurement at multiple skeleton sites
ea0016p95
Effects on bone turnover and bone mineral density of levothyroxine suppressive therapy in patients with benign nodular goiter
ea0016p96
A new form of hereditary low-turnover osteoporosis in a 3-generation Finnish family
ea0016p97
In utero and postnatal exposure to phytoestrogens modulates the bone mineral density of juvenile and adult female wistar rats
ea0016p98
Secondary osteoporosis in man with aromatase deficiency: positives and negatives of estrogen therapy
ea0016p99
Agressive course of primary hyperparathyroidism caused by parathyroid carcinoma: case report
ea0016p100
FGF-23 and parameters of calcium and bone metabolism are positively influenced by GH replacement in adult growth hormone deficiency patients from the KIMS survey
ea0016p101
Endogeneous calciotropic and sex hormones and their relationship to bone mineral density in elderly females
ea0016p102
Exercise effect on bone anabolic hormones in elderly females: preliminary results of the senior fitness and prevention study (SEFIP)
ea0016p103
Clinical cases
A case of pseudopseudohypoparathyroidism with vitamin D deficiency
ea0016p104
A case of hyperaldosteronism due to bilateral macronodular adenomas with a renal mass in the left kidney
ea0016p105
Coexistance of parathyroid tumors with metachronous metastasis to the thyroid from renal clear cell carcinoma 20 years after nephrectomy
ea0016p106
Adrenal incidentalomas: which do we send for operation?
ea0016p107
Prolonged QT interval on the electrocardiogram in hypogonadal men
ea0016p108
Recurrent silent and post-partum thyroiditis in a single patient: evidence for a common aetiology
ea0016p109
Successful pregnancy outcome in a woman with acromegaly treated with lanreotide before and briefly during the first trimester of gestation
ea0016p110
Androgenic alopecia and hirsutism in a 73-year-old woman: careful re-evaluation of 'normal' imaging findings may lead to a rare diagnosis
ea0016p111
Children with growth retardation due to Rathke cleft cyst
ea0016p112
Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy
ea0016p113
Severe secondary osteoporosis in a patient with systemic mastocytosis stabilized by therapy with low-dose pegylated interferon alpha
ea0016p114
The influence of application site on testosterone serum concentrations after transdermal testosterone gel
ea0016p115
Increased frequency of Cushing's disease in patients with polycystic ovary syndrome
ea0016p116
Simultaneous detection of a heterozygous deletion in the STX16 gene and loss of methylation at GNAS1A by methylation-specific MLPA in two patients with pseudohypoparathyroidism type 1b (PHP 1b)
ea0016p117
TSH-secreting pituitary adenoma with GH-secretion
ea0016p118
Atypical laminopathy revealed by non-insulin dependent diabetes and conduction disturbances
ea0016p119
A Korean adult-onset type II citrullinemia with confirmed SLC25A13 mutation: a case report
ea0016p120
Primary squamous cell carcinoma of the thyroid
ea0016p121
Cardiometabolic risk factors in type 2 diabetic patients according to the definition for metabolic syndrome of International Diabetes Federation
ea0016p122
Fungal thyroiditis
ea0016p123
Increased levels of thyroid hormone and a non-suppressed TSH in two patients due to different mutations in T3 receptor beta (TR[beta])
ea0016p124
Effects of gender on clinical and biochemical features in Cushing's disease
ea0016p125
Failure of restrictive bariatric surgery -- sleeve gastrectomy -- in severe hypothalamic obesity secondary to Langerhans cell histiocytosis: a case report
ea0016p126
Is metoclopramide test useful in differentiation of the clinical form of hyperprolactinemia?
ea0016p127
Conversion from hypothyroidism due to Hashimoto's thyroiditis into Graves' hyperthyroidism in a case of thyroid hemiagenesis
ea0016p128
Ovarian hyperthecosis in a postmenopausal woman
ea0016p129
A fetus affected with a complete androgen insensitivity syndrome due to a novel mutation of AR and persistent Mullerian structures
ea0016p130
A long standing lymph node metastasis from occult thyroid papillary carcinoma: 10 years evolution until positive diagnosis
ea0016p131
FSH secreting pituitary adenoma: a case report
ea0016p132
Cross-sex hormonal therapy in transsexuals: a survey in Munich
ea0016p133
Optimization of chronic disease patient management: a pilot project on Sandostatin[R] LAR[R] treatment via homecare service
ea0016p134
Acute neurological onset in primary hyperaldosteronism
ea0016p135
Tumors of the clivus: various entities requiring different therapies
ea0016p136
A novel compound heterozygous mutation of the aromatase gene in adult man: new insight into the role of estrogen on gonadal development
ea0016p137
Galactocele and prolactinoma: a pathogenic association?
ea0016p138
Biochemical markers of bone in coeliac disease
ea0016p139
Prospective study of latent pernicious anemia markers in patients with type 1 diabetes mellitus
ea0016p140
Monogenic form of polycystic ovary syndrome due to mutation in lamin A/C gene: case report of two sisters
ea0016p141
Coexistence of primary hyperparathyroidism and hyperthyroidism due to Graves' disease: case report
ea0016p142
Partial pituitary failure presenting as adrenocortical failure in pregnancy
ea0016p143
The safety and efficacy of injectable testosterone undecanoate during routine clinical management of hypogonadism: an analysis from a long-term 'real-life' study
ea0016p144
Hypercalcemic renal failure in splenic sarcoidosis
ea0016p145
Testosterone treatment improves muscle strength, lean mass and quality of life in prefrail and frail elderly men: results from a randomised double-blind placebo-controlled study
ea0016p146
Severe nonalcoholic fatty liver disease in a young woman with polycystic ovary syndrome and insulin resistance: case report
ea0016p147
A case of hungry bone syndrome during therapy with methimazole for hyperthyroidism
ea0016p148
Giant myelolipoma in a patient affected by 17-[alpha]-hydroxylase deficiency and [beta]-thalassemic trait
ea0016p149
Subclinical Cushing's syndrome (CS): role of 131I-iodomethylnorcholesterol scintigraphy in predicting the evolution of the disease
ea0016p150
Two unusual cases with pancytopenia associated with Sheehan's syndrome
ea0016p151
Pituitary carcinoma presenting as Cushing's disease
ea0016p152
Hypoglycaemia following gastric banding
ea0016p153
Serious hypocalcemia as the first display of coeliac disease of the Down syndrome patient
ea0016p154
Brown tumor of the mandible and osteitis fibrosa cystica in hyperparathyroidism: a rare disease mimicking an osseous metastasized malignancy
ea0016p155
Consequences of childhood onset growth hormone deficiency (COGHD) in cases of familial hypopituitarism
ea0016p156
Giant prolactinoma: what is the best therapy?
ea0016p157
Does cyproterone acetate promote multiple meningiomas?
ea0016p158
How the workup of low renin hypertension lead to the diagnosis of SIADH
ea0016p159
Clinical efficacy of intramuscular versus oral testosterone undecanoate in adult men with hypogonadotropic hypogonadism
ea0016p160
Coincidence of a diaphragma sellae meningioma and two different pituitary adenoma subtypes in a single intra- and suprasellar lesion
ea0016p161
Etiology of patients attending an outpatient clinic of a tertiary care centre for primary amenorrhoea: a retrospective study
ea0016p162
Clinical presentation of a patient with pseudohypoparathyroidism type 1a (Albright syndrome)
ea0016p163
Comparative endocrinology
c-AMP production in in vitro VIP- and PACAP-induced adrenal secretion of the lizard Podarcis sicula
ea0016p164
Chemokine CXCL10 gene polymorphisms in Addison's disease
ea0016p165
The prevalence of transsexualism (TS) and other gender identity disorders (GID) in Russia: an overview of existing data
ea0016p166
In vivo effects of chronic contamination with 137 cesium on testicular and adrenal steroidogenesis
ea0016p167
Contamination with depleted or enriched uranium differently affects steroidogenesis metabolism in rat
ea0016p168
Endocrine effects of a coat-color mutation Star in farm-bred silver foxes Vulpes vulpus
ea0016p169
Serum levels of the soluble isoform of the receptor of advanced glycosylated end products (sRAGE) are increased in women with PCOS
ea0016p170
Effects of dietary advanced glycation end products on endocrine and metabolic parameters of women with polycystic ovarian syndrome
ea0016p171
Diabetes and cardiovascular diseases
Changes in the sympathetic and sensory innervation of the tail artery, adrenal gland and male reproductive organs of glucose-intolerant Goto-Kakazaki (GK) rats
ea0016p172
Anxieties of type one diabetic patients
ea0016p173
Opportunistic screening for type 2 diabetes mellitus in the out-patient clinic: experience from Basrah, Southern Iraq
ea0016p174
Long term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes mellitus
ea0016p175
Adiponectin stimulates monocytic release of CCL2, -3, -4 and -5 concomitantly reduces the surface abundance of CCR1, -2 and -5
ea0016p176
Effects of the omega-3 polyunsaturated fatty acids in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetes mellitus patients
ea0016p177
Omega-3 polyunsaturated fatty acids and simvastatin in the treatment of type 2 diabetic patients with cardiomyopathy
ea0016p178
Degree of control of cardiovascular risk factors (CRFs) in patients with type 2 diabetes mellitus (T2DM) stratified by diabetes therapy
ea0016p179
Determination of asymptomatic interacranial stenotic arteries in diabetic and hypertensive old patients by transcranial doppler sonography
ea0016p180
The impact of family history of type 2 diabetes mellitus on insulin sensitivity in lean subjects with polycystic ovary syndrome
ea0016p181
Rapid acting insulin analogues are superior to normal human insulin in intensified insulin treatment of type 2 diabetes mellitus
ea0016p182
Melatonin--insulin relationships in rats and humans
ea0016p183
Effects of micronutrients supplementation on lipid peroxidation in Type 2 diabetes
ea0016p184
Metabolic improvement in diabetic patients under education before implantation of the insulin sibcutaneous continuous infusion (ISCI)
ea0016p185
Comparison of patient's life quality between inhalated insulin therapy (Exubera) and conventional treatment
ea0016p186
Satisfaction degree and metabolic control in patients with glucose continuous monitoring system
ea0016p187
Metabolic control and quality of life in patients with DM1 and insulin pump therapy
ea0016p188
Utility of ambulatory blood pressure monitoring in diabetological consulting
ea0016p189
The knowledge of society about risk factors for cardiovascular diseases like obesity and prevention of it
ea0016p190
Mediterranean-style diet attenuates inflammation and atherosclerosis markers in type 2 diabetic patients
ea0016p191
Endothelin-1 is correlated with TGF-[beta]1 but not with glycemic control in normotensive subjects with type 2 diabetes
ea0016p192
Use of three dose premixed aspart: clinical correlates
ea0016p193
Relationship between admission blood glucose (ABG) and homocysteine (HC) levels in patients with acute coronary syndromes (ACS)
ea0016p194
K121Q PC-1 gene polymorphism is not associated with postpartum type 2 diabetes in gestacional diabetes mellitus patients
ea0016p195
Improvement of exercise capacity, muscle strength and insulin resistance in elderly patients with heart failure after treatment with long acting testosterone: a randomized clinical trial
ea0016p196
Circulating Reg1-[beta] plasma levels: potential marker of beta cell regeneration?
ea0016p197
Influence of ethnicity on prevalence of gestational diabetes
ea0016p198
24 h glycemia variability correlates with arterial structure alteration in type 1 diabetes
ea0016p199
Relationship between nerve conduction velocity with uncoupling protein 2 promoter polymorphism -866G/A and A allele frequency in type 2 diabetic patients with diabetic peripheral neuropathy
ea0016p200
No genetic impact of the SOCS3-gene on T2DM
ea0016p201
Atherosclerosis in premenopausal diabetic women with or without polycystic ovary syndrome
ea0016p202
Effects of testosterone and sildenafil on cytokines and angiogenic factors: a randomized controlled trial
ea0016p203
Smoking shortens insulin-free interval in type 2 diabetics
ea0016p204
Glycemic variability analyze with different glucometers
ea0016p205
Evaluation of continuous subcutaneous insulin infusion in type 1 diabetes
ea0016p206
Elevated plasma fatty acid levels are associated with myocardial triglyceride accumulation and diastolic dysfunction in type 2 diabetes mellitus which can be reversed by acipimox
ea0016p207
May testosterone therapy be the key to metabolic syndrome (MS) treatment in men?
ea0016p208
Relationship of insulin sensitivity with carotid intima media thickness in patients with type 2 diabetes mellitus
ea0016p209
Diabetic survival with HD: 10-years follow-up
ea0016p210
Markers of oxidative stress and antioxidant status in patients with gestational diabetes
ea0016p211
Adipokine profile in gestationa diabetes mellitus
ea0016p212
Patients with type 2 diabetes mellitus have intima media thickness of carotid artery wall equal to that of a decade older non-diabetic patients
ea0016p213
Kidney transplantation and diabetes mellitus: continuous monitoring of glucose
ea0016p214
Metabolic changes induced by glucose infusion in persons with Glu23Lys polymorphism
ea0016p215
Effects of testosterone administration in male patients with heart failure with and without hypogonadism
ea0016p216
GC-tofMS metabolite profiling in the pancreatic beta cell line INS-1 under chronic glucose stress conditions
ea0016p217
Diabetes management and metabolic control are below expectations in specialist diabetes practice in Portugal
ea0016p218
Glucose metabolism alterations in non-diabetic patients undergoing cardiac rehabilitation programs
ea0016p219
GDM in women younger and older than 28 years: are there any differences in phenotype and biochemical markers?
ea0016p220
SelS/Tanis controls insulin sensitivity and is regulated by acute phase and diet
ea0016p221
Atherosclerotic factors, low antioxidant defense and cardiovascular diseases in retinal occlusions and anterior ischemic optic neuropathy
ea0016p222
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in polycystic ovary syndrome
ea0016p223
Atorvastatin ameliorates penile erection and sildenafil responsiveness in two distinct animal models of chemical diabetes and inhibits high glucose-induced alterations in human penile smooth muscle cells
ea0016p224
Circulating endotoxin as a potential biomarker and mediator of inflammation: influenced by diabetic therapies
ea0016p225
Serum adiponectin concentration is not dependent on inflammatory process of periodontium in patients with primary hypertension: preliminary results
ea0016p226
The association between adipocytokine profiles and insulin resistance in obese subjects
ea0016p227
Vitamin D deficiency is associated with heart failure and sudden cardiac death: cross-sectional and mortality data of 3299 patients referred to coronary angiography
ea0016p228
Retrovirally transduced, antigen-specific T cells for therapy of type 1 diabetes
ea0016p229
Induction of autoantigen-specific tolerance by retroviral transduction of hematopoetic stem cells with GAD65
ea0016p230
Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients
ea0016p231
Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy
ea0016p232
Quality of diabetes shared care in patients with diabetes type 2 in the diabetes clinic of Fredericia hospital
ea0016p233
Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients
ea0016p234
Cumulative incidence, timing and risk factors for thyroid dysfunction in 144 Romanian patients treated with amiodarone
ea0016p235
Changes in glucose profiles in fasting patients with type 2 diabetes mellitus during Ramadan: analysis of CGMS data in patients in the UAE
ea0016p236
Diabetic ketoacidosis in two periods: XX--XXI centuries
ea0016p237
Endothelin-1 and diabetes: influence of cronic metabolic control
ea0016p238
Subclinical alterations of blood pressure associated to clasical cardiovascular risk factors in patients with type 1 diabetes
ea0016p239
Cognitive dysfunction in diabetics: can we predict it, can we protect them?
ea0016p240
Iliofemoral arterial occlusion in type 2 diabetics shortens life duration to the greatest extent: 10 years follow up study
ea0016p241
Influence of obesity and insulin resistance on scavenger receptor CD36 expression on monocytes in young women
ea0016p242
Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy
ea0016p243
Psychological symptoms and quality of life among diabetic patients: a comparative study
ea0016p244
Correlation between inflammation markers and plasma fasting glucose in overweight and obese women
ea0016p245
Phenotypically heterogenous neonatal diabetes within one family caused by a new mutation in the sulphonylurea receptor SUR1 (ABCC8)
ea0016p246
Continuous subcutaneous insulin infusion with U-500 insulin is better than pramlintide in highly insulin resistant patient with type 2 diabetes
ea0016p247
Systematic exercise can further improve glycaemic control and physical fitness in physically active women with type 2 diabetes
ea0016p248
Early major complications at diabetics in coronary care unit
ea0016p249
Nebivolol in diabetic patients with chronic heart failure
ea0016p250
Frequency of hypertension studied by ambulatory blood pressure monitoring in type two diabetes
ea0016p251
Concentrations of steroid hormones different from estradiol may constitute risk factors of coronary artery disease in women
ea0016p252
The stress-related protein p8 protects beta cells from streptozotocin (STZ)-induced cell death in vitro
ea0016p253
Increased serum AGEs is a distinct finding in lean women with PCOS
ea0016p254
Importance of vasopressin and aldosterone for clinical outcome of patients after cardiac arrest
ea0016p255
Concentration of interleukins as prognostic factor in patients after cardiac arrest
ea0016p256
Cytokines secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grae systemic inflammation
ea0016p257
Rapid glucose sprayTM for the management of hypoglycaemia in children with type 1 diabetes
ea0016p258
Obestatin inhibits high glucose-induced reactive oxygen species production and apoptosis in bovine aortic endothelial cells
ea0016p259
The high prevalence of testosterone deficiency syndrome and erectile dysfunctions in the aging men with diabetes mellitus type 2
ea0016p260
The influence of testosteone replacement therapy on erectile dysfunctions in aging men with testosterone deficiency and diabetes mellitus type 2
ea0016p261
Endocrine disruptors
Lipid peroxidation, antioxidant enzymes activities in testis and spermatotoxicity of rats during short-term exposure to atrazine
ea0016p262
Endocrine disruption in lower vertebrates: Xenobiotic exposure affects testicular structure and biochemical composition of semen in a male teleost
ea0016p263
Investigating the effects of Liquorice consumption on Salivary Steroid hormones profile and blood pressure in healthy volunteers
ea0016p264
Clinical and laboratory symptoms of metabolic syndrome in women in climacteric period
ea0016p265
Functioning of endothelium in metabolic syndrome in the climacteric period of women
ea0016p266
New hepatic autoantigens in mice with APS-1 like disease
ea0016p267
Thyroid gland hormonal disturbances after iodine excess among children
ea0016p268
The UV absorber 4-methylbenzylidene-camphor (4-MBC) causes effects comparable to primary hypothyroidism
ea0016p269
Serum level of vitamin A, transthyretine and retinol binding protein in a region polluted by polychlorinated biphenyls in a long term
ea0016p270
Endocrine tumours
The comparison of serum VEGF levels between patients with metastatic and non-metastatic thyroid cancer, and patients with non-toxic multinodular goiter
ea0016p271
Special multiple endocrine neoplasia (MEN)
ea0016p272
The early results of the treatment of well differentiated thyroid cancer and its dependence on chosen factors
ea0016p273
Variability in rensponse to octreotide in patients with insulinoma detected by 111In-octreotide scintigraphy (Octreoscan)
ea0016p274
Nerve vagus schwannoma
ea0016p275
Use of multispine computed tomography in diagnostics of ectopic acth-syndrome
ea0016p276
Rottlerin inhibits migration of thyroid follicular carcinoma through destablization of the focal adhesion complex
ea0016p277
The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in large intestine metastases into liver
ea0016p278
PTHrP and HRG outcomes in MCF7 breast cancer cells transfected with HER receptors gene
ea0016p279
Type 1 iodothyronine deiodinase (D1) enzymatic activity is not reduced in liver focal nodular hyperplasia (FNH)
ea0016p280
An unusual case of painful gynaecomastia due to large adrenocortical tumour
ea0016p281
Screening of MEN1 gene in patients with either classic or variant MEN1 presentation
ea0016p282
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism in MEN-1 patients
ea0016p283
Correlation between postoperative hypothyroidism and seric homocysteine at the patients with thyroid carcinoma
ea0016p284
The role of parathyroid hormone-related protein on gynecomatia in patients with Klinefelter's syndrome and idiopathic gynecomastia
ea0016p285
Two new mutations in the RET protooncogene: R770Q in coincidence with Y791N in the same family with medullary thyroid carcinoma
ea0016p286
The role of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG/PET-CT) in the follow-up of differentiated thyroid cancer (DTC)
ea0016p287
Effects of the potent deacetylase inhibitor Panobinostat (LBH589) against poorly differentiated and anaplastic thyroid cancer cells
ea0016p288
Cytoplasmic shift of AUF1 in thyroid carcinoma
ea0016p289
Down-regulation of ENO1/MBP-1 gene products by retinoic acid (RA) causes decreased proliferation of the follicular thyroid carcinoma cell line FTC-133
ea0016p290
Differences in the gene expression patterns of several immune related genes in various human adrenocortical tumors
ea0016p291
Different gene expression patterns of histamine related genes in human adrenocortical tumors
ea0016p292
The prevalence of chosen complications in 72 acromegalics
ea0016p293
Expression of the somatostatin receptors (SSTRs) in patients with gastro-pancreatic neuroendocrine tumours (GEP-NET) and medullary thyroid cancers (MTC)
ea0016p294
Melatonin restores the basal level of lipid peroxidation in rat tissues under conditions of exposure to potassium bromate
ea0016p295
Relaxin and S100A4 alter the invasive potential in estrogen-independent human MDA-MB-231 breast cancer cells
ea0016p296
The Relaxin peptide is a novel regulator of S100A4 (metastasin) in thyroid carcinoma cells
ea0016p297
Cyclic Cushing disease: clinical case
ea0016p298
Adrenal ganglioneuroma: a new cause of increased serum calcitonin
ea0016p299
Proteomic profile of GH-secreting versus non-functioning pituitary tumors
ea0016p300
Genetic testing of RET protooncogene in multiple endocrine neoplasie type 2 and medullary thyroid carcinoma
ea0016p301
Impact of the use of recombinant TSH stimulated thyroglobulin measurement on health related quality of life in patients in follow-up for differentiated thyroid carcinoma (DTC)
ea0016p302
Cushings' syndrome due to ectopic ACTH secretion: four cases
ea0016p303
Inhibition of intracellular signaling pathways and induction of cell cycle arrest by the multi-kinase inhibitor sorafenib in thyroid carcinoma cells
ea0016p304
A rare case of hiperandrogenism bilateral Leydig cell tumor of the ovary
ea0016p305
Distinct catecholamine phenotypes in hereditary pheochromocytoma
ea0016p306
VDR gene polymorphisms in patients with differentiated thyroid cancer
ea0016p307
ERCC1 expression in adrenocortical carcinoma: relationship with baseline characteristics and response to platinum-based chemotherapy
ea0016p308
Leptin exerts apoptotic effects and regulates androgen receptors in human prostate cancer cells
ea0016p309
Long-term survival after surgical treatment in patients of adrenocortical carcinoma
ea0016p310
Parathyroid-hormone related- Peptide and PTHrP receptor type 1 are expressed in human adrenocortical carcinoma and regulate cell proliferation and apoptosis in H295R an adrenocortical-derived cell line
ea0016p311
Prognostic factors in localized adrenocortical carcinoma (ACC) after complete resection
ea0016p312
Multi-center, observational study on Sandostatin LAR treatment patients with acromegaly in Poland: preliminary report
ea0016p313
A study on investigations for localizing insulinoma
ea0016p314
Epidemiology of pituitary tumours in Iceland 1955-2007: a Nationwide Study
ea0016p315
Effects of pasireotide on bronchial carcinoids in primary culture
ea0016p316
The prognostic factors in adrenocortical carcinoma
ea0016p317
Cushing's syndrome due to a pigmented nodular adrenocortical disease and a acromegaly corresponding to a Carney complex (CNC)
ea0016p318
Self-observations of total life situation in patients with Acromegalia
ea0016p319
Mitotane induces a concentration-dependent impairment of platelet aggregation in patients with adrenocortical carcinoma
ea0016p320
One hundred minimally invasive parathyroidectomies without intraoperative localisation and PTH monitoring
ea0016p321
Effect of Ginkgo biloba extract supplementation on genotoxic damage after thyroid remnant ablation by 131I
ea0016p322
Neuroendocrine tumours (NETs): one centre experience
ea0016p323
Abnormalities in glucose tolerance in acromegalic patients
ea0016p324
Mutations in the ret proto-oncogene in Romanian patients with multiple endocrine neoplasia type 2
ea0016p325
Is the early postoperative hormonal assessment a helpful predictor of the long term remission in secreting pituitary adenomas after transsphenoidal adenomectomy?
ea0016p326
Prognostic value of 100 mcg s.c. octreotide test (SHort Octreotide Test - SHOT) for prediction of medical treatment outcome in patients with acromegaly
ea0016p327
Cushing syndrome with an atypical evolution
ea0016p328
Parathyroid carcinoma treated with cinacalcet: a preliminary report
ea0016p329
Ovarian serous and mucinous tumors of low malignant potential: patterns of stromal invasion
ea0016p330
Novel MEN1 germline mutations and clinical features in Greek patients with multiple endocrine neoplasia type 1
ea0016p331
Ghrelin and its receptor are present in an ectopic ACTH lung neuroendocrine tumour causing Cushing's syndrome: potential pathophysiological implications
ea0016p332
Deficits in the clinical management of patients with adrenocortical carcinoma in Germany
ea0016p333
The cAMP analog 8CL-cAMP enhances PKA RIIb, triggers apoptosis and blocks cells at S and G2 cell cycle phases after 4 days of treatment in the human adrenocortical cells H295R.
ea0016p334
Hyperprolactinaemia: different clinical expression in childhood
ea0016p335
G12/13-dependent growth of small cell lung cancer cells in vitro and in vivo
ea0016p336
High prevalence of pituitary adenomas: a cross-sectional study in the city of Banbury (Oxfordshire)
ea0016p337
Gastric NETs: new diagnostic and therapeutic approach
ea0016p338
Fenotypes in patients with Y791F mutation of RET protooncogene
ea0016p339
Insulin sensitivity in a patient with gastric ghrelinoma
ea0016p340
Association of genetic variants of somatostatin receptor 5 with acromegaly
ea0016p341
Cushing syndrome: cycling around diagnosis
ea0016p342
Raloxifene induces growth arrest and apoptosis in prostate cell lines expressing both ER[alpha] and [beta]
ea0016p343
Pituitary adenomas: the reality of Braga
ea0016p344
Deregulated Wnt/[beta]-catenin signaling in breast cancer: the LRP5[delta] receptor
ea0016p345
p107Rbl1 is an haploinsufficient tumor suppressor in mouse pituitary
ea0016p346
Immunohistochemical evaluation of ghrelin expression in somatotroph and non-functioning pituitary tumours
ea0016p347
Growth and development
Secular height changes in Greek conscripts
ea0016p348
Population-based data of quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA)
ea0016p349
A study of IGF-1 serum concentrations and kinetics of growth hormone assays in stimulation tests used for diagnosing insufficient somatotrope secretion
ea0016p350
45,X/46,XX mosaicism: clinical implications in adulthood
ea0016p351
Evaluation of insulin sensitivity in growth hormone (GH) deficient children before and at the end of rhGH therapy
ea0016p352
Impaired Se metabolism provokes gender-specific growth defects in mice
ea0016p353
Potential ageing effects in long-term cultured mouse neurospheres
ea0016p354
Health-related quality of life in constitutionally tall children and adolescents
ea0016p355
Utility of 2-h nocturnal assessment of growth hormone (GH) secretion as a screening procedure in diagnosing GH deficiency in short children: own observations
ea0016p356
Abstract unavailable
ea0016p357
Comparison between the results of 2-h and 6-h assessment of nocturnal growth hormone (GH) secretion in short children - preliminary report
ea0016p358
Lipid peroxidation as possible mechanism of apoptosis activation in low birth weight children
ea0016p359
Study of dimer and oligomers of human growth hormone
ea0016p360
Changes in cortisol and insulin during pregnancy in relation to basal metabolic rate (BMR)
ea0016p361
Growth factors
Does IGF-BP3 assay contribute to the diagnosis of GHD in children?
ea0016p362
Does administration of octreotide acetate prevent development of diabetic nephropathy? an ultrastructural evaluation of the effects of octreotide acetate on kidney tisssue in Streptozotocin induced diabetic rats
ea0016p363
Measurement of neutralising antibodies to human interferon-[beta] by quantitative analysis of type 1 interferon inducible 6-16 mRNA
ea0016p364
Association between serum levels of insulin-like growth factor-I and development of congestive heart failure: a prospective study in a normal population
ea0016p365
Effects of growth hormone and of insulin-like growth factor-I on iron-induced lipid peroxidation in rat liver and porcine thyroid homogenates
ea0016p366
Protective effects of growth hormone and of insulin-like growth factor-I against lipid peroxidation in iron sensitive rat tissue
ea0016p367
Leptin and ghrelin serum levels during an oral glucose tolerance test in patients with growth hormone deficiency with and without growth hormone substitution
ea0016p368
New occurrence of diabetes mellitus in patients with adult onset GH deficiency (GHD) on GH therapy is dependent on the presence of metabolic syndrome at baseline: data from the Hypopituitary Control and Complication Study (HypoCCS)
ea0016p369
Associations of anthropometric parameters with serum IGF-1, TSH, prolactin and testosterone levels
ea0016p370
The cytosine-adenine (CA) repeat polymorphism in the promoter region of the insulin-like growth factor-1 (IGF-1) gene is not associated with the GH dose in GH-deficient adults
ea0016p371
Acromegaly is associated with high plasma fibrinogen and C reactive protein values after normalization of growth hormone and IGF-1
ea0016p372
Low insulin-like growth factor (IGF) I, IGF binding protein-3 and acid labile subunit (ALS) levels in young ischemic stroke: a prospective case-control study
ea0016p373
Pituitary hormone axes in constitutionally tall adolescents
ea0016p374
TIMP-1 regulates the secretion of soluble VEGF receptor 1 in human endothelial cells
ea0016p375
Overexpression of IGFBP-2 in transgenic mice affects muscle protein accretion, skeletal myofibre growth and metabolism
ea0016p376
Neuroendocrinology
Turner syndrome: body composition and psychological state
ea0016p377
Can early evening melatonin treatment prevent relapse after sleep deprivation?
ea0016p378
Reduction of food intake by insulin detemir in comparison to regular human insulin
ea0016p379
Pituitary insufficiency after traumatic brain injury and the coherence with psychological disorders
ea0016p380
Review of pituitary adenomas diagnosed in Burgos (Spain)
ea0016p381
Residual adverse vascular risk and oxidative stress in treated adult panhypopituitarism
ea0016p382
Is total and acylated ghrelin secretion after oral glucose modified by acromegaly?
ea0016p383
Hypothalamic-pituitary insufficiency following infectious diseases of the central nervous system
ea0016p384
The choice of therapy in acromegaly: results of treatment at a tertiary care hospital
ea0016p385
Isolated GH deficiency of adult-onset in the KIMS database: prevalence, clinical presentation, and response to GH replacement
ea0016p386
Efficacy of slow release formulation of lanreotide (Somatuline AutogelR 120 mg) in patients with acromegaly: single center experience
ea0016p387
Smoking causes increased androgen levels in perimenopausal women
ea0016p388
Body fat excess and GH-stimulated levels in adult patients with Prader-Willi syndrome
ea0016p389
Cardiovascular risk factors in adult onset growth hormone deficiency (AO-GHD) without growth hormone replacement: follow-up period seven years
ea0016p390
Nocturnal HPA axis activity is blunted by increased plasma glucose concentrations
ea0016p391
Macroprolactinemia seems to have a positive effect on platelet activation through ADP stimulation
ea0016p392
A study of the serotoninergic tone in healthy subjects and diabetic patients treated by a clinical-paedagogic approach (Group Care) or traditional care
ea0016p393
Growth hormone (GH) treatment on atherosclerosis: results of a 5 years open, prospective, controlled study in male patients with severe GH deficiency
ea0016p394
Dopamine receptor expression and dopamine agonist effectiveness in corticotroph pituitary tumors: comparison with clinical, biochemical radiological and pathological features of patients with Cushing's disease
ea0016p395
The effects of growth hormone deficiency following moderate and severe traumatic brain injury on cognitive functions
ea0016p396
Pharmacological prevention of long-term neuroendocrine and behavioral changes in prenatally stressed rats
ea0016p397
Genetic and clinical analyses in an Italian series of idiopathic hypogonadotropic hypogonadism
ea0016p398
Four years of growth hormone (GH) therapy improves markers of cardiovascular risk in GH deficient (GHD) survivors of childhood acute lymphoblastic leukaemia (ALL)
ea0016p399
Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome
ea0016p400
Serum and glucocorticoid-induced kinase 1 mediates basal and stimulated POMC transcription in pituitary corticotrophs
ea0016p401
Effect of hyperprolactinemia in male patients consulting for sexual dysfunction
ea0016p402
Effects of 6 months growth hormone treatment in GH deficient patients (GHD) long after traumatic brain injury (TBI)
ea0016p403
Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients
ea0016p404
Performance characteristics of serum and salivary hormone quantification for luteal phase confirmation in behavioural studies
ea0016p405
Malignant diseases in our patients with acromegaly
ea0016p406
Pituitary abscess: a case report
ea0016p407
Effects of weight gain on serum adiponectin, leptin and ghrelin concentrations in patients with anorexia nervosa
ea0016p408
Evaluation of verbal memory function in acromegalic patients treated with or without conventional radiotherapy after transsphenoidal surgery
ea0016p409
The role of inferior petrosal sinus sampling for ACTH-dependent Cushing's syndrome
ea0016p410
Comparison of visceral adipose tissue content between diabetic and nondiabetic acromegalic patients
ea0016p411
A non-functioning pituitary carcinoma with cerebellar metastases
ea0016p412
Impact of hyperglycaemia on carotid intima-media thickness in acromegaly
ea0016p413
Autoimmune hypophysitis and isolated corticotrophin deficiency
ea0016p414
Heel pad thickness in diabetic and nondiabetic acromegalic patients
ea0016p415
Perioperative steroid treatment is not routinely required in endoscopic transphenoidal surgery for clinically non functioning pituitary adenomas (NFPA)
ea0016p416
Pituitary deficiencies after autologous bone marrow transplantation
ea0016p417
Consequences of isolation stress on glucocorticoid regulating genes and behavioural response in postnatal pigs
ea0016p418
Demography, characteristics and outcome of acromegaly at King Hussein medical centre amman Jordan
ea0016p419
Sleep quality in patients of a primary health care unit and its relationships with antropometric parametters
ea0016p420
Glucose-dependent insulinotropic polypeptide receptor (GIPR) in human pituitary adenomas
ea0016p421
Macroprolactinaemia in men
ea0016p422
Age-dependent expression of ret receptor from perinatal life to adulthood
ea0016p423
Midnight salivary cortisol (MSC) to assess the outcome of transsphenoidal surgery (TSS) in Cushing's disease (CD)
ea0016p424
Tests of growth hormone (GH) status in severe GH deficiency: do they identify a similar phenotype? Insight from the KIMS database
ea0016p425
Enos, P22phox and apoE gene polymorphism associations with circulating hormone levels in the elderly
ea0016p426
Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with growth hormone (GH) treated GH deficiency? A litterature analysis
ea0016p427
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), during lifespan in humans
ea0016p428
Variable effects of preproTRH(178-199) on ACTH secretion by human corticotrope tumors
ea0016p429
Endocrine features of aging and cognitive function in women
ea0016p430
Effect of a six-month treatment with octreotide long acting repeatable (LAR) on mean platelet volume in patients with acromegaly
ea0016p431
GHRH as a possible allosteric ligand of the ghrelin receptor GHS-R1a
ea0016p432
Unusual pattern of pituitary insufficiencies following traumatic brain injury evaluated by insulin tolerance test
ea0016p433
Hypopituitarism and features of the metabolic syndrome in patients with traumatic brain injury (TBI)
ea0016p434
Lymphocytic infundibulo-neurohypophysitis with diabetes insipidus and favorable evolution after glucocorticoid treatment
ea0016p435
Prolactin levels in patients with cirrhosis increase with severity of liver disease
ea0016p436
Pituitary dysfunction in patients after stroke
ea0016p437
Abstract unavailable
ea0016p438
A comparison between three automated chemiluminescence assays for growth hormone: on the use of recombinant hGH as a primary calibrant
ea0016p439
Acute effects of the intranasal administration of growth hormone-releasing hormone (GHRH) on nocturnal memory consolidation in waking young men
ea0016p440
Cardiovascular risk profile in 81 acromegalic patients: a cross-sectional clinical study
ea0016p441
Diurnal cortisol profile changes in the acute phase after aneurysmal subarachnoid hemorrhage
ea0016p442
Pregnancy in the rat is a physiological state of leptin resistance
ea0016p443
Effects of intranasal atrial natriutetic peptide (ANP) and insulin on sleep-associated pituitary-adrenal inhibition in elderly humans
ea0016p444
Long-term treatment with dopamine agonists is not associated with increased prevalence of valvular heart disease in patients with prolactinomas
ea0016p445
Expansion of grey and white matter volumes and increased white matter gliosis in acromegaly: a clinicoradiological study of 43 patients
ea0016p446
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy
ea0016p447
Glucose infusion affects memory function but not ACTH concentrations in patients with Addison's disease
ea0016p448
Prevalence of metabolic syndrome in adult hypopituitaric patients with GH deficiency (GHD)
ea0016p449
The benefit of long-term growth hormone replacement therapy in adults, results of the German KIMS database
ea0016p450
Panhypopituitarism due to hemochromatosis: a case report
ea0016p451
Pituitary autoantibodies in patients with central diabetes insipidus and polydipsia: evidence of autoimmune pituitary involvement in both states
ea0016p452
Endocrinopathies with langerhans cell histiocytosis (LCH): nine cases
ea0016p453
Aryl hydrocarbon receptor interacting protein (AIP) expression in human pituitary adenomas
ea0016p454
Systemic comorbidities induce early vascular alterations in patients with active acromegaly
ea0016p455
Use of videocapsule endoscopy (VCE) for the detection of small bowel tumors in patients with acromegaly
ea0016p456
Fatigue in breast cancer patients during chemotherapy: correlation with neuromuscular dysfunction and IGF-1 plasma levels
ea0016p457
Effect of GH replacement on coronary flow reserve (CFR) and on some cardiovascular risk factors in adult GHD patients
ea0016p458
Effect of cholescytokinin (CCK) on food intake and brainstem and hypothalamic neuronal activation and its modulation by glucocorticoid
ea0016p459
Intrasellar and parasellar tumors - concomitant symptoms and clinical syndromes
ea0016p460
d3-growth hormone receptor polymorphism (d3-GHR) is associated with low BMI and better glucose metabolism in acromegaly
ea0016p461
Correlation of IGF-1 and IGFBP-3 levels with liver function in patients following traumatic brain injury or subarachnoidal haemorrhage
ea0016p462
Identification and molecular characterization of new somatostatin receptor subtype 5 truncated isoforms in rodents
ea0016p463
Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury
ea0016p464
Gh/Igf-1 control and tumor growth reduction in active acromegalic patients on Octreotide LAR
ea0016p465
Effects of growth hormone replacement in 28 patients with growth hormone deficiency
ea0016p466
Starting dose of 10 mg Octreotide-LAR appears ineffective for biochemical control in the majority of acromegalic patients: interim analysis from the OASIS trial
ea0016p467
Factors associated with response to medical therapy in patients with Acromegaly
ea0016p468
Diagnosis of SIAD: Fractional urate excretion closes the diagnostic gap in hyponatremic patients on diuretics
ea0016p469
Circulating visfatin and adiponectin levels are reduced in women after long-term remission of Cushing's syndrome
ea0016p470
The impact of conventional radiotherapy on Wisconsin card sorting test performance in acromegalic patients treated with transsphenoidal surgery
ea0016p471
Somatotropin release inhibiting factor (SRIF) downregulates Wnt/B-catenin pathway in ACTH-secreting pituitary cell line AtT-20
ea0016p472
Identification of ACTH-secreting adenomas in Cushing's disease using intraoperative high-frequency direct contact ultrasound. Preleminary results
ea0016p473
Macroprolactinaemia: a clinical problem
ea0016p474
Prolaktinoma and hyperprolactinemia in Albania
ea0016p475
Prospective comparison of the glucagon stimulation test (GST) with the insulin tolerance test (ITT) in patients following pituitary surgery
ea0016p476
Expression of ghrelin and opioid mRNAs in the hypothalamo-pituitary-adrenal axis after immune system activation
ea0016p477
Cyclical Cushing's syndrome: prevalence in patients with Cushing's disease
ea0016p478
Familial acromegaly: family screening and assessment in the familial isolated pituitary adenoma (FIPA)
ea0016p479
Hypopituitarism following traumatism brain injury in the West Indies: a pilot study between July 2005 and July 2006
ea0016p480
Hypopituitarism after traumatic brain injury and its possible relation with neurocognitive and psychiatric disturbances
ea0016p481
Endoscopic pituitary surgery as the primary treatment for acromegaly: a prospective study in a specialised centre
ea0016p482
mTOR inhibitors rapamycin and RAD001 (Everolimus) induce antiproliferative effects in GH3 cell line and human pituitary adenomas
ea0016p483
Obesity
The influence of low calorie-high dietary fibres diet on the change of parameters of the metabolic syndrome
ea0016p484
Estradiol reverts the impairment of the natriuretic peptide system in a menopause-associated obesity model
ea0016p485
The effect of various dyslipidemia management guidelines on the assessment of LDL-C goal attainment in population-based studies
ea0016p486
Bariatric surgery for patients whit morbid obesity: a cohort study
ea0016p487
Overweight and obesity in Iranian adolescents
ea0016p488
Obesity and it's hormonal profile in saudi population
ea0016p489
Adiponectin induces CXCL8 in primary human hepatocytes via the adiponectin receptor 1
ea0016p490
Iranian overweight children and adolescents: who are seeking weight loss treatment?
ea0016p491
Metabolic and hormonal patterns in men under the age 40 years with obesity and metabolic syndrome
ea0016p492
Prevalence of overweight in comparison to wasting, among Iranian under 5 year-old children in urban and rural
ea0016p493
Gene expression profiling in skeletal muscle from diet-induced obesity susceptible rats
ea0016p494
A pharmacologic sympathectomy prevents the development of obesity and insulin resistance in the high fat fed rat
ea0016p495
Lipid-loaded hepatocytes release soluble factors that activate hepatic stellate cells: a new in vitro model to study fibrogenesis in NASH
ea0016p496
Insulin resistance, atherogenic dyslipidemia and other atherogenic factors in simple obesity and obesity with Acanthosis nigricans (an) in childhood
ea0016p497
Tribbles pseudokinases and adipose tissue biology
ea0016p498
Differences in the POMC methylation pattern in normal weight and obese individuals and regulation of MC-4R promoter activity by DNA methylation
ea0016p499
Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test in obese and overweight individuals, but correlate with some indices of insulin resistance
ea0016p500
Overweight adolescents, a group at risk for metabolic syndrome (Tehran Adolescent Obesity Study)
ea0016p501
The obesity, physical activity status and dietary pattern in 10-12 years old girls of a mountainous region in north of Iran
ea0016p502
Expression of the different components of the endocannabinoid system (ECs) in morbid obesity
ea0016p503
Plasma adrenomedullin positively correlates to body mass index, and significantly decreases after bariatric surgery
ea0016p504
Plasma osteopontin correlates with insulin resistance in obese subjects, but increases following bariatric surgery parallel to other markers of bone turnover
ea0016p505
Cholinergic regulation of meal induced ghrelin and PYY release is impaired in obesity
ea0016p506
Serum adiponectin levels in children with nonspecific infections: relations with fever and acute phase reactants
ea0016p507
NCEP-ATP-III defined metabolic syndrome, type 2 diabetes mellitus and prevalence of hypogonadism in male patients with sexual dysfunction
ea0016p508
Interleukin-1sz is a positive regulator of TIARP/STAMP2 in 3T3-L1 adipocytes
ea0016p509
Daily and nightly urinary free cortisol ratio as a marker of the hypothalamic-pituitary-adrenal (HPA) axis activity in abdominal obesity
ea0016p510
Impact of dietary management and diet duration on body weight and metabolic and endocrine changes in rats fed a high fat/low carbohydrate diet
ea0016p511
No feedback inhibition of obestatin during acylated ghrelin infusion in humans
ea0016p512
Prevalence and characterization of metabolic syndrome (MS) in different classes of obesity and related endocrine factors
ea0016p513
Relationship among stress, weight gain and the activity of the hypothalamic-pituitary-adrenal (HPA) axis
ea0016p514
Glucose-dependent insulinotropic polypeptide (GIP) receptor knock-out prevents ovariectomy-induced obesity in mice
ea0016p515
Chronic central infusion of a ghrelin receptor (GHS-R1A) antagonist to rats: impact on ICV ghrelin-induced food intake and altered body composition
ea0016p516
Increased unsaturated fatty acids biosynthesis when pyruvate carboxylase is suppressed in adipocytes
ea0016p517
Glomerular filtration rates as a cardiometabolic risk markers in obese women
ea0016p518
In the metabolic syndrome adrenergic overdrive is independent on the obese state
ea0016p519
Changes of the testosterone levels in young males with obesity and metabolic syndrome
ea0016p520
Expression of adrenergic receptors and atrial natriuretic peptide in human adipose tissue of severe obese women and Rosiglitazone action during differentiation of human pre-adipocytes
ea0016p521
Glucose-dependent insulinotropic polypeptide downregulates expression and enzyme activity of 11[beta]-Hydroxysteroid Dehydrogenase type 1
ea0016p522
Obesity in GDM: a registry of GDM in Portugal
ea0016p523
Sleep loss and metabolic response to breakfast
ea0016p524
Abdominal fat and atheromatosis risk factors in non-obese healthy subjects
ea0016p525
The effect of fasting on substrate metabolism and growth hormone signaling
ea0016p526
Regulation of acylation stimulating protein by insulin in overweight and obese postmenopausal women: a MONET study
ea0016p527
Prevalence of obesity and overweight in Iranian middle aged adults
ea0016p528
Determination of dimerisation domains of the human melanocortin 4 receptor
ea0016p529
Fluctuation of orexin, ghrelin and melatonin levels during daytime
ea0016p530
Metabolic syndrome and endothelial dysfunction in women with polycystic ovary syndrome - relationship with insulin sensitivity
ea0016p531
Diabetogenic effects of a continuous infusion of acylated ghrelin in normal and type 2 diabetic patients
ea0016p532
Pentraxin 3 production in human visceral adipose tissue is associated with cardiovascular risk factors
ea0016p533
Insulin and glucose regulates omentin-1, a novel adipokine: relation to women with the polycyastic ovary synfrome
ea0016p534
Postnatal determination of ghrelin secretion levels and sexual dimorfism in the rat
ea0016p535
The effect of polyunsaturated fatty acids enriched eggs on lipid profile and inflammatory markers
ea0016p536
Carbohydrate and lipid oxidation in relation to serum adiponectin concentration in women with anorexia nervosa
ea0016p537
Molecular insights in dysfunctions of the human melanocortin-4-receptor (MC4R) caused by mutations in the third transmembrane domain (TM3) and the second intracellular loop
ea0016p538
Ghrelin gene polymorphisms in Prader Willi Syndrome
ea0016p539
Retinol-binding protein 4 is independently associated with insulin resistance in PCOS women
ea0016p540
Glucagon suppression of total but not of acylated ghrelin is preserved in obesity: the impact on appetite control
ea0016p541
The sirtuin activating compound resveratrol decreases GH transcription
ea0016p542
Glucose-dependent insulinotropic polypeptide (GIP) modulates inflammatory markers and regulates cell proliferation in subcutaneous adipose tissue
ea0016p543
Serum soluble E-selectin concentration in relation to insulin resistance and metabolic inflexibility in obese women
ea0016p544
The volume of left hepatic lobe as metabolic marker, correlates with weight and not with height, both in obese or non-obese women and men
ea0016p545
Decreased NK cell functions from obese F344 rats can be altered after transfusion in lean littermates
ea0016p546
Central resistin regulates both hypothalamic and peripheral lipid metabolism in a nutritional dependent fashion
ea0016p547
Changes in physical activity and changes in body weight: a longitudinal assessment in the SUN dynamic cohort
ea0016p548
The relationship between alteration in plasma inflammation, metabolic biomarkers and severe steatosis in a group of morbidly obese patients
ea0016p549
Endocrine and metabolic alterations in narcoleptic patients as result of orexin-A reduction
ea0016p550
Prevalence of non alcoholic steatohepatitis in diabetic patients with morbid obesity
ea0016p551
Dual effect of the adapter Grb14 on insulin action in primary mouse hepatocytes
ea0016p552
Consequences of the modification of Grb14 expression level on adipocyte differentiation and metabolism
ea0016p553
25-Hydroxyvitamin D deficiency in premenopausal morbidly obese women
ea0016p554
Association study on three single nucleotide polymorphisms upstream and in the GIPR in obese and lean children from Berlin
ea0016p555
Screening for mutations in the glucose-dependent insulinotrophic polypeptide receptor gene (GIPR) in obese patients with disturbed glucose tolerance
ea0016p556
Analysis of the central glucocorticoid feedback in patients with obesity, diabetes, and depression
ea0016p557
Evaluation of metabolic syndrome in patients with diabetes mellitus type 2 using different criteria: National Cholesterol Education Program's Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF)
ea0016p558
Relation of high-sensitive C-reactive protein and metabolic risk factors in overweight and obese women
ea0016p559
Relationship of visceral adiposity with plasma adiponectin concentration: effect of weight loss
ea0016p560
The interrelationship between leptin, visfatin and CRP levels and insulin sensitivity assessed by euglycaemic clamp in obese women
ea0016p561
Obesity and adipocytokines
ea0016p562
ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocyte-mediated aldosterone secretion
ea0016p563
Leptin decreases and glucose deprivation increases the generation of the soluble leptin receptor (sOb-R) in a cell model
ea0016p564
The impact of middle term feeding with organic, low input and conventional diets on body composition and plasma leptin concentration in male rats
ea0016p565
Prospective, Placebo controlled, randomized treatment of 67 obese children/adolescents with metformin
ea0016p566
Hyperandrogenism in pre- and post-menopausal obese women
ea0016p567
Relationship between obesity, IL-17 and IL-23 and insulin resistance
ea0016p568
NMR study of ghrelin and desacyl-ghrelin with the growth hormone releasing receptor type 1a using living cells
ea0016p569
C-reactive protein and insulin sensitivity in severe obese women with and without metabolic syndrome
ea0016p570
Inflammatory parameters in obesity: lack of influence of weight loss
ea0016p571
Activated protein C levels in obesity and weight loss influence
ea0016p572
Determination of obesity and its relationship with hypertension among Semnanian adults, Iran
ea0016p573
Development of metabolic syndrome is associated with impaired quality of life: longitudinal data from the North West Adelaide Health Study
ea0016p574
Novel potent and selective non-peptide ligands of ghrelin receptor: characterization of endocrine and extraendocrine actions
ea0016p575
Hypoadiponectinemia but not activation of immune markers is associated with impaired glucose metabolism in morbidly obese patients
ea0016p576
Genetic determination of leptin, insulin and adiponectin levels in the Berlin Fat Mouse Inbred 860 line
ea0016p577
Paediatric endocrinology
The prevalence of endocrine complications in patients with thalassemia major
ea0016p578
The role of thiocyanate in the etiology of residual goiter in Semirom, an iodine replete area
ea0016p579
Structural study on the effect of maternal diabetes on fetal endocrine pancreas
ea0016p580
Successful treatment of isolated growth hormone deficiency type 1a with recombinant human growth hormone
ea0016p581
Polyendocrinopathy in children, adolescents and young adults with type 1 Diabetes: results from 23837 patients in the German/Austrian DPV-Wiss-database
ea0016p582
Comparison of vitamin D status, sun-exposure and personalised UVB-radiation dosimetry of mildly pigmented, breastfed newborns during their first 6-8 weeks of life in Perth, Western Australia and Berlin, Germany
ea0016p583
Growth hormone deficient children born small-for-gestational-age need higher than replacement dose of hGH for successful treatment
ea0016p584
Autosomal dominant hypophosphatemic rickets (ADHR) due to a novel mutation in the FGF23 gene
ea0016p585
The role of desmopressin test in the diagnosis of young patients with Cushing's disease
ea0016p586
Evaluation of Intergrated [18F]FDOPA-PET/CT for identification of focal forms of Congenital Hyperinsulinism (CHI)
ea0016p587
Epigenetic defects at GNAS DMRs in PHP-Ia patients lacking coding GNAS mutations
ea0016p588
Hypospadias and micropenis in congenital adrenal hyperplasia: a case study
ea0016p589
Increased hyperinsulinism and insulin resistance, and decreased antioxidant defense, in children and adolescents with pre-metabolic versus metabolic syndromes
ea0016p590
Prevalence of obesity and metabolic syndrome among Spanish adolescents
ea0016p591
Kinetic study of ldl oxidation in female progeny with positive family history of cardiovascular diseases and/or hyperlipidemia
ea0016p592
Final height and timing of menarche after treatment for idiopathic central precocious puberty (CPP)
ea0016p593
The coincidence of Poland syndrome and Turner syndrome
ea0016p594
Day profiles of salivary 17-hydroxyprogesterone for the control of glucocorticoid therapy in adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
ea0016p595
The superoxide dismutase and lipid peroxide in children with Down syndrome and congenital heart disease
ea0016p596
New clinical features and detailed genetic analysis of heterozygous 17q12 deletion syndrome, leading to loss of TCF2 and MODY5
ea0016p597
Aspects and features of type 2 diabetes and the metabolic syndrome in obese children and adolescents
ea0016p598
Autoimmune polyendocrine syndrome type 1 in West Northern France: phenotypic and genotypic description, and use of immunosuppressive therapies
ea0016p599
High incidence of obesity and insulin resistance in prepubertal children, born too small for their gestational age
ea0016p600
Prolactinomas in pediatric age
ea0016p601
Molecular genetic analysis of a patient with hyperinsulinism and deafness
ea0016p602
Insipidus diabetes revealing a chordomas of a skull base in a child
ea0016p603
Reproduction
Age-adjusted variations in dynamics of the follicular growth in relation to ovarian steroid hormones in the domestic hen
ea0016p604
The relationship between semen parameters and blood hormone in men with congenital absence of vas deferens
ea0016p605
Pituitary primary cell culture and effect of its secretion on endocrine activity of incubated ovarian follicles (Study of pituitary-ovary axis): in the model of fish (common carp)
ea0016p606
Serum stable metabolites of nitric oxide (NOx) concentrations in pre- and post-menopausal women on transdermal estradiol therapy
ea0016p607
Expression of ghrelin receptor, GHSR-1a in the pig ovary and its role in ovarian function
ea0016p608
A comparison between flutamide and finasteride plus flutamide combination in the treatment of hirsutism
ea0016p609
Quantitative determination of aromatase and 5-[alpha] reductase mRNA and polymorphisms in the aromatase and 5-[alpha] reductase genes in idiopathic hirsutism
ea0016p610
Endometriotic cell proliferation and survival are inhibited by somatostatin analogues and GHRH antagonists
ea0016p611
Developmental and genetic changes in chemosensory activation of testicular testosterone response to a receptive female and sexual behaviour in laboratory male mice
ea0016p612
Growth hormone improves semen volume, sperm count and motility in men with idiopathic normogonadotropic infertility
ea0016p613
Expression and direct effects of adiponectin in rat testis
ea0016p614
Association between psychiatric symptoms and erectile dysfunction
ea0016p615
Estimated cardiovascular risk and arteriogenic erectile dysfunction
ea0016p616
Anti-Mullerian hormone levels in women with polycystic ovary syndrome before and after metformin therapy
ea0016p617
Catecholestogens inhibit endothelial cell growth in an angiogenesis bioassay
ea0016p618
Intima-media tickness of carotid artery in young women with polycystic ovary syndrome
ea0016p619
Basal INSL3 levels predict LH and androgen response to GnRH analogue in PCOS women
ea0016p620
Semen quality in men with obesity and metabolic syndrome
ea0016p621
Low-grade chronic inflammation in first-degree relatives of women with polycystic ovary syndrome
ea0016p622
Pathogenesis of the congenital forms of hypogonadotropic hypogonadism
ea0016p623
Role of lysosomal acid lipase on the hydrolysis of LDL-transported DHEA-fatty acid esters in HeLa cells
ea0016p624
Hydrolysis and metabolism of LDL-transported DHEA-fatty acid esters in HeLa cells
ea0016p625
Influence of the 5 [alpha]-reductase inhibitor type 2 on circulating neuroactive steroids
ea0016p626
Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transexuals (FtM)
ea0016p627
Bilateral cavernous neurotomy induces hypogonadotropic hypogonadism in rat: effect of testosterone and tadalafil supplementation
ea0016p628
Effect of phosphatidylinositol 3-kinase inhibition on estradiol-induced proliferation and hyperplasia formation in the mouse uterus
ea0016p629
Systemic and seminal antioxidant systems in infertile men with chronic alcohol abuse
ea0016p630
Development of an ElecsysR Testosterone II Immunoassay with an improved performance for measurement of testosterone in women
ea0016p631
Dynamic changes in the serum inhibin A and B levels correlated to reproductive hormones in women
ea0016p632
Polymorphisms of the sex hormone-binding globulin gene contribute to the interindividual variation of gonadal steroid hormone blood levels in men
ea0016p633
Leydig cells activity is impaired in patients with Sertoli cell-only syndrome
ea0016p634
Effects of Tadalafil on nocturnal penile tumescence and rigidity in normal men: randomized, placebo-controlled, crossover study
ea0016p635
Gonadotropin releasing hormone analogue in cyclophosphamide-induced premature gonadal failure prevention
ea0016p636
Topographical effects of functional prostanoid and oxytocin receptors on mid-cycle contractions in isolated human myometrium
ea0016p637
The importance of the (TTTA)n polymorphism of aromatase (CYP19) gene in menarche
ea0016p638
Weight loss determines a complete remission of the polycystic ovary syndrome in most of obese women
ea0016p639
The role of sex hormone-binding globulin (SHBG) and aromatase (CYP19) gene variants in the development of polycystic ovary syndrome (PCOS)
ea0016p640
Serum concentrations of atherogenic proteins Neutrophil gelatinase-associated lipocalin and its complex with Matrix Metaloproteinase-9 are significantly lower in women with Polycystic Ovary Syndrome: hint of a protective mechanism?
ea0016p641
PACAP and PACAP receptors in the testis of cartilaginous fish Torpedo marmorata
ea0016p642
Simultaneous profile of prostanoids in pregnant preterm non labouring, term non labouring and term labouring myometrium using ESI-LC-MS
ea0016p643
The incidence of adiponectin gene polymorphism and its relation to serum adiponectin and androgen levels, insulin resistance and clinical parameters in polycystic ovary syndrome
ea0016p644
Serum osteoprotegerin in polycystic ovary syndrome
ea0016p645
Relation of proatherogenic lipid profile and insulin resistance in PCOS
ea0016p646
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
ea0016p647
Insulin resistance in patients with polycystic ovary syndrome and idiopathic hirsutism
ea0016p648
Accumulation of dietary glycotoxins in the reproductive system of normal female rats
ea0016p649
Reactive nitrogen species in the chemical biology of sperm functions
ea0016p650
Apoptosis related signaling in the reproductive system
ea0016p651
Signal transduction
Insulin regulation of proliferation involves activation of akt and erk 1/2 signaling pathways in vascular smooth muscle cells
ea0016p652
The hinge region of the human TSH-receptor (hTSHR) mediates the activity of a superagonistic human TSH analog and bovine TSH
ea0016p653
Melatonin acts on pancreatic [beta]-cells via melatonin receptors using the cAMP-, IP3- and probably also the cGMP-signalling pathway
ea0016p654
D327N SHBG is more effective than wild-type as modulator of estradiol signalling in breast cancer cells
ea0016p655
Consequences of PRKAR1A (Carney complex gene) inactivation on cellular and subcellular PKA activity monitored by FRET-based reporters
ea0016p656
Orexins stimulate steroidogenic acute regulatory (StAR) protein expression through multiple signalling pathways
ea0016p657
G protein coupling and adenylyl cyclase inhibition are mediated by the DRY motif in the second intracellular domain of the SST5 receptor
ea0016p658
Ligand-dependent internalization of somatostatin receptors
ea0016p659
Combined rapamycin-octreotide treatment exerts its superior antiproliferative action by dramatically increasing p27/Kip1 expression
ea0016p660
NOD proteins expression and function in the pituitary folliculostellate cells
ea0016p661
Corticotropin releasing hormone receptor signalling pathways and regulation of NOSIII activity in syncytialized BeWo cells
ea0016p662
Modulation of endothelial NF-[kappa]B transcription factors by carbohydrates
ea0016p663
cAMP/PKA and ERK1/2 dependent feedback mechanisms regulating type 2 CRH receptor signalling
ea0016p664
Signalling properties of corticotropin-releasing hormone receptor (CRH-R1/2) in adrenal (H295R) cells
ea0016p665
Steroid receptors
Thyroid receptors play a suppressor role by reducing pituitary tumor transforming gene 1 in human hepatocellular carcinoma cells
ea0016p666
Modulation of creatine kinase specific activity by triiodothyronine in rat organs
ea0016p667
Testosterone increases kidney weight in orchiectomized male Wistar rats but not dihydrotestosterone
ea0016p668
XbaI polymorphism of ESR1 gene might influence the effect of raloxifene on the endothelial function
ea0016p669
Altered androgen metabolism and signalling during tissue remodelling of the prostatic stroma: implications for prostate cancer and benign prostatic hyperplasia
ea0016p670
(Lack of) Epigenetic variability in the human glucocorticoid receptor promoter CpG island
ea0016p671
The vitamin D receptor agonist elocalcitol up-regulates L-type Ca2+ channel activity in human and rat bladder
ea0016p672
Vitamin D receptor gene polymorphism influences the amplitude of 1,25(OH)2D3 immune impact
ea0016p673
Long-term storage of blood spots: is retesting for newborn 17 OH-progesterone reliable?
ea0016p674
Bioavailable estradiol in men: relationship with age and testosterone
ea0016p675
Glucocorticoid receptor gene polymorphisms in patients with Cushing's disease and adrenal Cushing's syndrome
ea0016p676
High level of different dietary fat modifies protein androgen receptors level in rat prostate tissues
ea0016p677
Association of estrogen receptor alpha and beta gene polymorphisms with sex steroid levels in men
ea0016p678
Thyroid
Autoimmune thyroiditis (AIT) as a high-risk factor for thyroid cancer (TC)
ea0016p679
The influence of cure of subclinical hyperthyreosis on heart rate and autonomous nervous sytem
ea0016p680
Radioactive iodide therapy for high-risk papillary thyroid carcinoma
ea0016p681
Smoking as a risk factor for thyroid volume change and incident goiter in a region of normalized iodine supply
ea0016p682
Hypothyroidism and renal failure
ea0016p683
Anti-BIP levels on Hashimoto's thyroiditis
ea0016p684
Neither total thyroidectomy nor radioiodine remnant ablation improved long-term outcome in 900 patients with papillary thyroid microcarcinoma treated during 1945 through 2004
ea0016p685
Is response bias in population studies on iodine supply and thyroid disorders neglectable?
ea0016p686
Expression of RNA-binding proteins TIAR and TIA-1 in thyroid tissues from patients with immune and non-immune thyroid diseases
ea0016p687
Thyroid function and volume changes in patients with end stage renal disease, before and after kidney transplantation
ea0016p688
Structure-function studies of thyrotropin using site-directed mutagenesis and gene transfer: development of new agonists and antagonists
ea0016p689
Clinicopathological characteristics of thyroid cancer in patients on dialysis for end-stage renal disease
ea0016p690
The TR[beta]1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells
ea0016p691
Rosiglitazone in two patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer
ea0016p692
Effects of 8-Cl-cAMP on growth and apoptotic process in poorly differentiated thyroid cancer cell lines
ea0016p693
Cyclin A and B1 are overexpressed in thyroid cancers which had been operated for indeterminate, nondiagnostic, or suspicious fine-needle aspirate results
ea0016p694
Semiquantitative evaluation of E-cadherin immunoexpression in the thyroid neoplasms
ea0016p695
Pronostic value of serum thyroglobulin measured before thyroid ablation with I131 in patients with papillary cancer meta-analysis
ea0016p696
Clinical features of TRAB negative Graves disease: a prospective study
ea0016p697
Absence of sonic hedgehog mutations in a large cohort of children with thyroid dysgenesis
ea0016p698
Thymic hyperplasia presenting as a neck mass in Graves' disease
ea0016p699
Cigarette smoking but not the TSHR germline polymorphism D727E is associated with toxic multinodular goitre (TMNG) and the thyroid volume
ea0016p700
Thyronamines are isozyme specific substrates of deiodinases
ea0016p701
The outcome of radioiodine therapy of hyperthyroidism: comparison of patients with a toxic nodular goiter and with Graves' disease
ea0016p702
Results of thyroxine therapy on thyroid nodules size in children with Hashimoto's thyroiditis
ea0016p703
Refetoff syndrome associated with other congenital diseases (case report)
ea0016p704